文献速递心外重症与机械循环支持

左心室辅助装置支持患者贫血的存在及其影响

Presence and impact of anemia in patients supported with left ventricular assist devices.
PubMed 文献 · J Heart Lung Transplant · 2023-04-29

基于INTERMACS数据库2008至2017年接受耐久性左心室辅助装置(LVAD)的19,509例成人患者,按贫血严重程度分层。中重度贫血在基线、6个月、第4年分别占45.2%、33.5%、32.3%。调整后术前贫血严重程度与更高死亡风险相关,随访中贫血进展与生活质量评分下降和6分钟步行距离缩短相关。

要点

  • 中重度贫血在LVAD植入基线占45.2%,6个月占33.5%,第4年占32.3%。
  • 调整后术前轻度贫血死亡HR 1.19(95%CI 1.05-1.35),中重度贫血HR 1.44(95%CI 1.28-1.62)。
  • 随访中贫血进展与堪萨斯城心肌病问卷评分降低和6分钟步行距离缩短相关。

核心结论

  • 在LVAD支持患者中贫血是常见合并症,随时间恶化与不良预后相关。

研究设计与样本

  • 从INTERMACS数据库识别2008年至2017年接受耐久性LVAD的成人患者,全队列按贫血严重程度分为无贫血、轻度和中重度三组。

主要发现

  • 分析19,509例患者(女性21.2%,年龄56.9±12.9岁),中重度贫血在基线占45.2%,6个月占33.5%,植入后第4年占32.3%。
  • 血红蛋白正常者在术前占24.4%,6个月占32.5%,植入后4年占36.6%。
  • 多变量线性混合效应回归显示,与LVAD存活者相比,LVAD非存活者平均血红蛋白随时间显著更低(β -0.233,95%CI -0.282至-0.185),且血红蛋白随时间下降幅度更大(β -0.032,95%CI -0.035至-0.028)。
  • 调整后Cox回归显示术前贫血严重程度与更高死亡率相关(轻度HR 1.19,95%CI 1.05-1.35;中重度HR 1.44,95%CI 1.28-1.62),竞争风险回归结果相似。
  • 随访期间贫血进展与堪萨斯城心肌病问卷评分降低和6分钟步行距离缩短相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on anemia and its effects on patients supported with continuous-flow left ventricular assist devices (LVADs) are lacking. OBJECTIVES: This study sought to describe the presence of anemia over time and investigate its association with mortality, quality of life, exercise capacity, and adverse events in LVAD patients. METHODS: Adults receiving durable LVADs between 2008 and 2017 were identified from the INTERMACS database. The full cohort was stratified according to anemia severity (no anemia, mild, and moderate-severe). RESULTS: The analysis of 19,509 patients (females: 21.2%, age: 56.9 ± 12.9 years) showed that moderate-severe anemia affected 45.2% of patients at baseline, 33.5% of them at 6 months, and 32.3% in the fourth year after implantation. The presence of normal hemoglobin was 24.4% before surgery, 32.5% at 6 months, and 36.6% at 4 years after implantation. Multivariable linear mixed-effect regression revealed that the average hemoglobin over time was significantly lower (β, -0.233, 95% confidence interval (CI): -0.282 to -0.185), and the reduction of hemoglobin over time was bigger (β, -0.032 95% CI: -0.035 to -0.028) for LVAD nonsurvivors compared with LVAD survivors. Adjusted Cox regression showed that the severity of preimplant anemia was associated with higher mortality (HR, mild: 1.19; 95% CI: 1.05-1.35 and moderate-severe: 1.44; 95% CI: 1.28-1.62), with similar results in competing risk regression. Anemia progression during follow-up was associated with decreased Kansas City Cardiomyopathy Questionnaire scores and shorter 6-minute walk distances. CONCLUSIONS: In patients supported with LVADs, anemia is a frequent comorbidity, and deterioration over time is associated with poor prognosis.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Tie H, Li T, Huang B, et al. Presence and impact of anemia in patients supported with left ventricular assist devices. J Heart Lung Transplant. 2023. PMID: 37127070. doi:10.1016/j.healun.2023.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。